Synt:em Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Synt:em General Information

Description

Developer of drugs for the treatment of central nervous system (CNS) disorders. The company is a biopharmaceutical business focused on the discovery and development of new drug candidates for CNS diseases. The company re-engineers therapeutic molecules using peptides, as a means of delivering them to the brain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Acquirer
Primary Office
  • Parc Scientifique
  • Georges Besse
  • 30035 Nîmes
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synt:em Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 01-Jan-2005 000.00 Completed Generating Revenue
8. Merger/Acquisition 03-Nov-2004 000.00 000.00 Cancelled
7. Later Stage VC 09-Jan-2002 00.00 000.00 Completed Generating Revenue
6. Later Stage VC 07-Mar-2001 000.00 000.00 Completed Generating Revenue
5. Early Stage VC 17-Nov-1999 00.000 Completed Startup
4. Early Stage VC 07-Jan-1998 00.00 00.000 Completed Startup
3. Early Stage VC 01-Dec-1997 00.00 00.000 Completed Startup
2. Early Stage VC 01-Jun-1997 $347K $810K Completed Startup
1. Early Stage VC $462K $462K Completed Startup
To view Synt:em’s complete valuation and funding history, request access »

Synt:em Executive Team (1)

Name Title Board Seat Contact Info
Michel Kaczorek Ph.D Chief Executive Officer & Founder
To view Synt:em’s complete executive team members history, request access »

Synt:em Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
Apax Partners (France) PE/Buyout Minority 000 0000 000000 0
Banexi Ventures Partners Venture Capital Minority 000 0000 000000 0
BankInvest Group Venture Capital Minority 000 0000 000000 0
Lombard Odier Darier Hentsch Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »